Cargando…
Transient T cell depletion causes regression of melanoma metastases
BACKGROUND: Cognate immunity against neoplastic cells depends on a balance between effector T cells and regulatory T (Treg) cells. Treg cells prevent immune attack against normal and neoplastic cells by directly suppressing the activation of effector CD4(+ )and CD8(+ )T cells. We postulated that a r...
Autores principales: | Rasku, Mary Ann, Clem, Amy L, Telang, Sucheta, Taft, Beverly, Gettings, Kelly, Gragg, Hana, Cramer, Daniel, Lear, Sheron C, McMasters, Kelly M, Miller, Donald M, Chesney, Jason |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330026/ https://www.ncbi.nlm.nih.gov/pubmed/18334033 http://dx.doi.org/10.1186/1479-5876-6-12 |
Ejemplares similares
-
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma
por: Telang, Sucheta, et al.
Publicado: (2011) -
Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers
por: Clem, Amy L, et al.
Publicado: (2007) -
Fructose-2,6-bisphosphate links glucose to survival and growth
por: Yalcin, Abdullah, et al.
Publicado: (2014) -
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation
por: Telang, Sucheta, et al.
Publicado: (2012) -
A Novel Small Molecule Antagonist of Choline Kinase-α That Simultaneously Suppresses MAPK and PI3K/AKT Signaling
por: Clem, Brian F., et al.
Publicado: (2011)